Quantcast
Last updated on April 19, 2014 at 9:20 EDT

Latest Abortifacients Stories

2013-05-02 08:38:08

Pivotal data for investigational controlled release misoprostol vaginal insert in the U.S. accepted for presentation NEW ORLEANS, May 2, 2013 /PRNewswire/ -- Ferring Pharmaceuticals will present efficacy and safety data from its Phase 3 EXPEDITE* study for its investigational controlled release misoprostol vaginal insert (MVI) at the 61(st) annual clinical meeting of the American College of Obstetricians and Gynecologists in New Orleans, May 4 - 8, 2013. Studies accepted for...

2013-02-12 08:30:08

SAN FRANCISCO, Feb. 12, 2013 /PRNewswire/ -- Ferring Pharmaceuticals will present pivotal Phase 3 efficacy and safety data from its EXPEDITE* study for its investigational controlled release misoprostol vaginal insert (MVI) at the 33(rd) annual meeting of the Society for Maternal-Fetal Medicine (SMFM) in San Francisco, February 11 - 16. These and other research findings formed the basis for Ferring's New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) supporting the use...

2012-10-23 11:24:41

PARSIPPANY, N.J., Oct. 23, 2012 /PRNewswire/ -- Ferring Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for its controlled release misoprostol vaginal insert (MVI). Ferring is seeking approval for the MVI for decreasing time to vaginal delivery in women with an unfavorable cervix (a cervix that has not yet softened and thinned so that dilation can take place) when used in sequential regimen with...

2012-02-09 08:30:00

Increasing access to mifepristone to improve women's reproductive health choices LONDON, Feb. 9, 2012 /PRNewswire-USNewswire/ -- WomanCare Global announced today that mifepristone has been added to their reproductive healthcare portfolio. Through an agreement with Linepharma, WomanCare Global will provide sales, marketing, provider training and distribution of mifepristone in seven European and seven African countries. (Logo: http://photos.prnewswire.com/prnh/20101018/DC83896LOGO...

2011-11-15 09:43:41

University of Oregon biologist finds unwanted plants don't necessarily have it easy in absence of old enemies After hiking in Oregon, a University of Oregon plant biologist suggests, people may want to brush off their shoes and comb through their dogs in an effort to curb the spread of an invasive grass that is expanding its range. The grass is false brome (Brachypodium sylvaticum), a native of Europe and Asia, which likely landed in Oregon by way of USDA experimental plots in 1939 near...

2011-03-07 21:38:28

URMC Research Confirms Possible Use of Drug for Painful Fibroids Research continues to show that the controversial abortion drug mifepristone might have another use, as a therapeutic option besides hysterectomy for women who suffer from severe symptoms associated with uterine fibroids. The University of Rochester Medical Center in 2004 began investigating mifepristone, in a class of drugs known as progesterone receptor modulators (PRMs), to treat fibroids, which affect roughly half of all...

2010-10-01 16:08:00

WASHINGTON, Oct. 1 /PRNewswire-USNewswire/ -- U.S. Centers for Disease Control and Prevention officials have disclosed that two mifepristone (RU-486)-induced deaths occurred in the past two years, bringing the total number of reported death related to RU-486 to 12. This announcement comes almost 10 years to the date after the Food and Drug Administration (FDA) approved the abortion drug, deeming it a major advancement for women's health and safe for public use. (Logo:...

2010-07-07 16:55:11

Molecular research shows misoprostol prevents cell communication A York University study has shown for the first time how the drug misoprostol, which has been linked to neurodevelopmental defects associated with autism, interferes with neuronal cell function. It is an important finding because misoprostol is similar in structure to naturally-occurring prostaglandins, which are the key signaling molecules produced by fatty acids in the brain. Past clinical studies have shown an association...

69f24bf4474aef94bf5d03cb803c21461
2010-03-31 06:22:55

A unique collection of St. John's wort (Hypericum) curated by Agricultural Research Service (ARS) scientists in Ames, Iowa, is providing university collaborators with genetically diverse, well-documented sources of this herb to use in studies examining its medicinal potential. In collaboration with Mark Widrlechner, a horticulturist with the ARS crop genebank at the North Central Regional Plant Introduction Station in Ames, scientists from the Center for Research on Botanical Dietary...

000e9e3d274ce8cc38c3e9d57879dd7c
2010-03-09 14:50:26

Swedish scientists are touting both the safety and effectiveness of home-based abortion medications for women who are 50 to 63 days pregnant, according to a March 9, 2010 Reuters report. Researchers at the Karolinska Institutet in Stockholm, led by Dr. Helena Kopp Kallner, state that this is the first survey to look at the use of the home-based procedure beyond 49 days post-conception. The procedure requires women to take a dose of mifepristone (also known as RU-486), followed three to four...